GSK and Novartis complete deals to reshape both drugmakers

LONDON (Reuters) - GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers.

from Reuters: Deals http://ift.tt/1wCRVF7